2024 Mid-Year Promotions Trends & Shopper Insights webinar

Consumers are overwhelmed. Will your marketing strategies cut through the noise and support them in their quest for savings? Compared to a year ago, half of consumers are putting more effort into planning their grocery trips. Are you reaching them in the right moments on the right channels as they build their lists?  Shoppers today expect more from the brands and retailers they engage with. How can you earn their favor and their business?

• Read more about 2024 Mid-Year Promotions Trends & Shopper Insights webinar

Delaying DSCSA Enforcement: The Right Decision for all the Right Reasons

Brian Nightengale, EVP and President of Healthcare at Inmar Intelligence, discusses the FDA’s recent decision to delay DSCSA enforcement. The delay offers pharmaceutical supply chain partners more time to fully achieve compliance and address operational challenges related to electronic interoperability and product traceability. Nightengale praises the decision as a thoughtful and proactive move to prevent disruptions in medication distribution while maintaining focus on patient safety and the integrity of the supply chain. He urges industry stakeholders to continue prioritizing efforts toward full DSCSA compliance.

• Read more about Delaying DSCSA Enforcement: The Right Decision for all the Right Reasons

On-Demand Webinar: The Power of Personalization & The Consumer Effect

Featuring PepsiCo Foods and Forrester Research Guest Speakers Personalization is more than just a trend; it’s one of the most powerful ways to improve consumer experiences and brand loyalty. As consumers increasingly expect tailored interactions across channels, brands are under pressure to deliver relevant, value-driven experiences. Meeting these expectations requires a strategic approach, combining data, creativity, and a deep understanding of consumer needs. 

• Read more about On-Demand Webinar: The Power of Personalization & The Consumer Effect

You Previously Qualified for a Small Dispenser DSCSA Exemption. Now What?

This article, originally published in Pharmacy Times, explores the DSCSA exemption for small dispensers and outlines their current and future regulatory obligations. It highlights the importance of staying compliant with key DSCSA requirements, including verifying trading partner licenses, maintaining product tracing documentation, and preparing for full electronic interoperability by the 2026 deadline.

• Read more about You Previously Qualified for a Small Dispenser DSCSA Exemption. Now What?

Inmar Intelligence Launches Commerce Fitscore™, Removing Subjectivity in Creator Selection

The first solution of its kind to identify creators based on their audience’s actual purchasing behavior. Inmar Intelligence, a leading data and technology company, today announced Commerce Fitscore™, the first solution of its kind that removes the subjectivity in creator selection and aligns creator selection with actual purchase behavior. Powered by Inmar’s first-party transactional data, Commerce Fitscore™ enables brands and retailers to select creators based on their audiences’ likelihood to drive sales performance.

• Read more about Inmar Intelligence Launches Commerce Fitscore™, Removing Subjectivity in Creator Selection

Rethinking Healthcare: Why Pharmacists Should Be Recognized as Providers

The article advocates for recognizing pharmacists as healthcare providers, enabling them to offer more comprehensive care and help address physician shortages, especially in underserved areas. This change would improve patient outcomes and expand healthcare access.

• Read more about Rethinking Healthcare: Why Pharmacists Should Be Recognized as Providers

Inmar Intelligence Appoints Pia Ostos as Chief Performance Officer

Inmar Intelligence, a leading data and technology company, is pleased to announce the appointment of Pia Ostos to the newly created role of Chief Performance Officer (CPO). This strategic addition to the Executive Leadership Team reflects Inmar’s ongoing commitment to delivering unparalleled value to its customers, partners, and stakeholders.

• Read more about Inmar Intelligence Appoints Pia Ostos as Chief Performance Officer

PBMs on Notice: NYCBS Victory Signals Major Changes Ahead

New York Cancer and Blood Specialists' $22M win against Caremark challenges PBM DIR fees, sparking potential legal and regulatory shifts. While a major victory for pharmacies, eliminating DIR fees could raise Medicare Part D premiums. Legislative and regulatory changes may reshape PBM practices and impact both pharmacies and beneficiaries.

• Read more about PBMs on Notice: NYCBS Victory Signals Major Changes Ahead

The Final Stretch: Is Your Pharmacy Ready for DSCSA Compliance?

As the November 27, 2024, deadline for full DSCSA compliance looms, the pharmacy industry finds itself in a critical phase of preparation. The recent NACDS Total Store Expo (TSE) in Boston revealed that many pharmacies are facing significant challenges, with the clock ticking down rapidly.

• Read more about The Final Stretch: Is Your Pharmacy Ready for DSCSA Compliance?